OptiCross Coronary Imaging Catheter, REF H749518080120
Published April 3, 2024 · Recall initiated: March 5, 2024
Summary
FDA records medical device Class II recall Z-1396-2024, published April 3, 2024 and initiated March 5, 2024. Recalling firm: Boston Scientific Corporation; Status: Ongoing; Reported quantity: 239 units; Lot: UDI/DI 08714729938415, Lot Numbers: 32426901, 32429407, 32625286. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boston Scientific Corporation
- Distributor
- International distribution to the country of Japan.
- Lot
- UDI/DI 08714729938415, Lot Numbers: 32426901, 32429407, 32625286
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDANaviFlex LW Pusher; Advx Panc. Stent 4/5F; Material Number (UPN): M00535030;October 21, 2026
- FDAImager II Angiographic Catheters M001314001 IMAGER II/5/ST/65/038 BX5; M001314011 IMAGER II/5/ST/100/038 BX5;September 30, 2026
- FDABoston Scientific Corporation StoneSmart Connect Console Contents: (1) Power Cord, (1) Power Adaptor, (1)DVISeptember 23, 2026
- FDALUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS US, Model NumberSeptember 9, 2026
- FDADiltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, RxApril 10, 2024
- FDAO.T.D - Optimum Traction Device - Street Orange. Single use traction splint.April 3, 2024
Questions about this recall
Was OptiCross Coronary Imaging Catheter, REF H749518080120 recalled?
Yes. FDA published recall Z-1396-2024 on April 3, 2024. Reported hazard: Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness.
What should I do if I have this product?
Voluntary: Firm initiated · Letter